Ole Haagen Nielsen

Ole Haagen Nielsen's AcademicInfluence.com Rankings

Ole Haagen Nielsen

Computer Science

#6411

World Rank

#6760

Historical Rank

Computational Linguistics

#1100

World Rank

#1114

Historical Rank

Machine Learning

#2071

World Rank

#2098

Historical Rank

Artificial Intelligence

#2331

World Rank

#2371

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Ole Haagen Nielsen's Degrees

PhD Computer Science University of Copenhagen
Masters Computer Science University of Copenhagen
Bachelors Computer Science University of Copenhagen

Similar Degrees You Can Earn

Why Is Ole Haagen Nielsen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ole Haagen Nielsen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Chronic inflammation: importance of NOD2 and NALP3 in interleukin‐1β generation (2006) (1045)
Familial occurrence of inflammatory bowel disease. (1991) (687)
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease (2000) (424)
YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration (2018) (352)
Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. (1992) (308)
Transplantation of Expanded Fetal Intestinal Progenitors Contributes to Colon Regeneration after Injury (2013) (293)
Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. (1991) (264)
Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management (2010) (257)
Pregnancy in ulcerative colitis. (1983) (250)
Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel Disease (2003) (247)
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. (2013) (238)
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease (2001) (232)
Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. (1990) (230)
Established and emerging biological activity markers of inflammatory bowel disease. (2000) (214)
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. (2000) (189)
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals (2014) (179)
Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study (2013) (174)
Tumor necrosis factor inhibitors for inflammatory bowel disease. (2013) (170)
Pregnancy in Crohn's disease. (1984) (154)
Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. (1997) (152)
Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. (2010) (150)
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. (2002) (144)
IL-33 is upregulated in colonocytes of ulcerative colitis. (2010) (141)
MAP kinases in inflammatory bowel disease. (2011) (135)
Drug Insight: aminosalicylates for the treatment of IBD (2007) (133)
Tumor necrosis factor inhibitors for inflammatory bowel disease. (2013) (132)
Kinetics of 5-aminosalicylic acid after jejunal instillation in man. (1983) (127)
Changes in Extent of Ulcerative Colitis A Study on the Course and Prognostic Factors (1996) (126)
Inflammatory pathways of importance for management of inflammatory bowel disease. (2014) (124)
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease (2013) (123)
Novel Targeted Therapies for Inflammatory Bowel Disease. (2017) (120)
Cytokines and Organ Failure in Acute Pancreatitis: Inflammatory Response in Acute Pancreatitis (2012) (119)
Safety of TNF-α inhibitors during IBD pregnancy: a systematic review (2013) (118)
Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. (1996) (114)
Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood (1984) (114)
5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa. (1987) (113)
Diagnosis and management of fistulizing Crohn's disease (2009) (111)
Changes in extent of ulcerative colitis: a study on the course and prognostic factors. (1996) (107)
Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome‐wide gene expression data (2009) (101)
Favourable effect of TNF‐α inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novoCARD15 mutation (2006) (98)
Protective effect of preexisting rotavirus‐specific immunoglobulin A against naturally acquired rotavirus infection in children (1987) (96)
Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease. (1982) (92)
Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. (2014) (92)
ATG16L1: A multifunctional susceptibility factor in Crohn disease (2015) (90)
Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation. (2014) (86)
Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis (1999) (85)
MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics. (2012) (84)
miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. (2013) (82)
Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases. (2016) (81)
Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis (2011) (80)
Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. (1994) (79)
Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. (2000) (69)
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease (2015) (69)
The role of CDX2 in intestinal homeostasis and inflammation. (2011) (68)
Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease. (2000) (68)
Malignant Diseases and Mortality Rate (1985) (68)
Interleukin-15 and its role in chronic inflammatory diseases (1998) (66)
Targeting JAK-STAT signal transduction in IBD. (2018) (66)
Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity. (2020) (65)
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial. (2006) (64)
Systemic inflammatory responses during laparoscopic and open inguinal hernia repair: a randomised prospective study. (2000) (64)
Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies (2018) (64)
Non-IBD and noninfectious colitis (2008) (63)
IBD medications during pregnancy and lactation (2014) (63)
Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. (1997) (63)
Mediators of inflammation in chronic inflammatory bowel disease. (1996) (62)
Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease (2017) (61)
New Strategies for Treatment of Inflammatory Bowel Disease (2014) (60)
CYSTIC FIBROSIS IN DENMARK IN THE PERIOD 1945‐1981 EVALUATION OF CENTRALIZED TREATMENT (1982) (59)
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils. (1987) (58)
Role of Vitamin D in the Natural History of Inflammatory Bowel Disease (2018) (58)
Systematic review with meta‐analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease (2019) (57)
Soluble L-selectin levels predict survival in sepsis (2002) (57)
The safety of osmotically acting cathartics in colonic cleansing (2010) (56)
Involvement of interleukin-4 and -10 in inflammatory bowel disease (1996) (55)
Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease. (2017) (55)
Inflammatory Bowel Disease Is Associated With an Increased Risk of Hospitalization for Heart Failure: A Danish Nationwide Cohort Study (2014) (55)
Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population‐based cohort study 1977‐2011 (2018) (54)
The normal cultivable microflora in upper jejunal fluid in healthy adults. (1984) (53)
Microscopic colitis: a missed diagnosis? (2004) (53)
Nitrofurantoin versus Trimethoprim Prophylaxis in Recurrent Urinary Tract Infection in Children (1990) (49)
Cystic Fibrosis in Denmark 1945 to 1985 (1988) (49)
COX-2–PGE2 Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis (2018) (48)
Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population‐Based Study (2017) (48)
IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis (2015) (47)
Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. (1983) (47)
Infliximab: mechanism of action beyond TNF-α neutralization in inflammatory bowel disease (2004) (46)
Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome. (1990) (46)
Rotavirus antibodies in the mother and her breast-fed infant. (1985) (46)
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease (2018) (45)
Intestinal barrier integrity and inflammatory bowel disease: Stem cell‐based approaches to regenerate the barrier (2018) (44)
Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis. (1986) (43)
A role for interleukin-33 in TH2-polarized intestinal inflammation? (2011) (42)
Recent Advances Using Immunomodulators for Inflammatory Bowel Disease (2013) (41)
Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease (2017) (40)
5-Aminosalicylic acid in the treatment of inflammatory bowel disease. (2009) (40)
Genome‐wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis (2010) (40)
Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease (2016) (39)
The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger (1987) (39)
Prognostic factors in neuroblastomas treated in denmark from 1943 to 1980: A statistical estimate of prognosis based on 253 cases (1986) (38)
Expression of the genes dualoxidase2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease (2007) (38)
Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid (1987) (38)
Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease (2009) (37)
Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy: A Systematic Review and Meta-analysis. (2020) (37)
The incidence of anemia, hypoproteinemia, and edema in infants as presenting symptoms of cystic fibrosis: a retrospective survey of the frequency of this symptom complex in 130 patients with cystic fibrosis. (1982) (37)
Simple and efficient method for isolation and cultivation of endoscopically obtained human colonocytes. (2003) (37)
Collagenous sprue: a coeliac disease look-alike with different treatment strategy (2014) (36)
Microbiological evaluation of jejunal aspirates and faecal samples after oral administration of bifidobacteria and lactic acid bacteria. (1994) (36)
TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis. (2012) (36)
Cytokines in inflammatory bowel disease. (1992) (36)
Non-tropical sprue. Malignant diseases and mortality rate. (1985) (36)
A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD) (1998) (35)
Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis. (1987) (35)
Technology Insight: metabonomics in gastroenterology—basic principles and potential clinical applications (2008) (35)
Managing vitamin D deficiency in inflammatory bowel disease (2019) (34)
Use of thiopurines in inflammatory bowel disease. (2013) (34)
Involvement of CDX2 in the cross talk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2. (2014) (33)
5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. (1984) (33)
Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. (1995) (33)
Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. (1993) (33)
Tissue‐regenerating functions of coagulation factor XIII (2013) (32)
Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease. (1987) (32)
Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease (1994) (32)
Epithelial apoptosis: Cause or consequence of ulcerative colitis? (2009) (31)
Expression of E-Selectin, Sialyl Lewis X, and Macrophage Inflammatory Protein-1α by Colonic Epithelial Cells in Ulcerative Colitis (1998) (31)
SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases (2020) (30)
Acute Gastroenteritis in Children Attending Day‐Care Centres with Special Reference to Rotavirus Infections (1987) (30)
Telomere dysfunction activates YAP1 to drive tissue inflammation (2020) (30)
CARD15 Single Nucleotide Polymorphisms 8, 12 and 13 Are Not Increased in Ethnic Danes with Sarcoidosis (2006) (29)
Continuous cytokine exposure of colonic epithelial cells induces DNA damage (2005) (29)
Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. (2013) (28)
Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond (2013) (28)
Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision. (1986) (28)
pcaGoPromoter - An R Package for Biological and Regulatory Interpretation of Principal Components in Genome-Wide Gene Expression Data (2012) (27)
Transcriptional Analysis of Left-sided Colitis, Pancolitis, and Ulcerative Colitis-associated Dysplasia (2014) (26)
A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine (2017) (26)
Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with99mTc-labeled pellets and scintigraphy (1986) (26)
In vitro studies on the significance of arachidonate metabolism and other oxidative processes in the inflammatory response of human neutrophils and macrophages. With special reference to chronic inflammatory bowel disease. (1988) (26)
Expression profiling of apoptosis‐related genes in enterocytes isolated from patients with ulcerative colitis (2006) (26)
The role and advances of immunomodulator therapy for inflammatory bowel disease (2015) (25)
Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD (2018) (25)
Proinflammatory cytokines in alcohol or gallstone induced acute pancreatitis. A prospective study. (2009) (25)
4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl. (1988) (25)
Will novel oral formulations change the management of inflammatory bowel disease? (2016) (24)
Alpha-Defensin DEFA1A3 Gene Copy Number Elevation in Danish Crohn’s Disease Patients (2011) (24)
Calcium Absorption and Acceptance of Low‐Lactose Milk Among Children with Primary Lactase Deficiency (1984) (24)
Interleukin-4 and 13 Induce the Expression and Release of Monocyte Chemoattractant Protein 1, Interleukin-6 and Stem Cell Factor From Human Detrusor Smooth Muscle Cells: Synergy With Interleukin-1β and Tumor Necrosis Factor-α (2006) (24)
Neuroblastomas treated at the four major child oncologic clinics in Denmark 1943-1980: an evaluation of 180 cases. (1985) (24)
The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method (2013) (24)
Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease. (2004) (23)
Mucosal vitamin D signaling in inflammatory bowel disease. (2020) (23)
Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway. (1989) (23)
Modulation of Gut Microbiota in Pathological States (2017) (23)
Colonic epithelial cell expression of ICAM-1 relates to loss of surface continuity: A comparative study of inflammatory bowel disease and colonic neoplasms (2006) (23)
Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis (2013) (22)
The Circulating Common Gamma Chain (CD132) in Inflammatory Bowel Disease (1998) (22)
Proximal collagenous gastroenteritides: Clinical management. A systematic review (2014) (22)
Same review quality in open versus blinded peer review in "Ugeskrift for Læger". (2012) (22)
Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994–2010: a population-based study (2016) (21)
Human recombinant interleukin-10 is safe and well tolerated but does not induce remission in steroid dependent Crohn's disease (2001) (21)
Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (2010) (21)
Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin in ulcerative colitis (1998) (21)
Upregulation of cIAP2 in regenerating colonocytes in ulcerative colitis (2007) (21)
How genetic testing can lead to targeted management of XIAP deficiency–related inflammatory bowel disease (2016) (21)
Evidence for Impaired CARD15 Signalling in Crohn's Disease without Disease Linked Variants (2009) (20)
ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis (2013) (20)
Identification, isolation and analysis of human gut-associated lymphoid tissues (2021) (20)
Attenuated apoptosis response to Fas‐ligand in active ulcerative colitis (2008) (20)
Recombinant human tumour necrosis factor increases cytosolic free calcium in murine fibroblasts and stimulates inositol phosphate formation in L-M and arachidonic acid release in 3T3 cells. (1990) (20)
Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis (1996) (20)
Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes. (1993) (19)
Arachidonic acid metabolism in human neutrophils: lack of effect of cyclosporine A. (1986) (19)
Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease (2014) (19)
Subcellular Localization of Intercellular Adhesion Molecule-1 in Colonic Mucosa in Ulcerative Colitis (2002) (19)
Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease (1998) (19)
Species‐specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll‐like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants (2015) (18)
Normal cultivable microflora in upper jejunal fluid in children without gastrointestinal disorders. (1984) (18)
Impact of T300A Variant of ATG16L1 on Antibacterial Response, Risk of Culture Positive Infections, and Clinical Course of Crohn's Disease (2015) (18)
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease (2016) (18)
Monitoring of omeprazole treatment in gastro-oesophageal reflux disease. (1996) (18)
Clinical phenotype and gene expression profile in Crohn's disease. (2007) (18)
Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials (2020) (18)
Clinical Reviews (2000) (17)
Correction: Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study (2013) (16)
Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis (2017) (16)
Acute Gastroenteritis in Children Attending Day‐Care Centres with Special Reference to Rotavirus Infections (1987) (16)
Cellular inhibitor of apoptosis protein 2 controls human colonic epithelial restitution, migration, and Rac1 activation. (2015) (15)
Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models (2003) (15)
[Probiotics for treating infectious diarrhea. A survey of a Cochrane review]. (2005) (15)
Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes (2016) (15)
Alpha-1 Antitrypsin and Granulocyte Colony-stimulating Factor as Serum Biomarkers of Disease Severity in Ulcerative Colitis (2015) (15)
Alcohol modulates circulating levels of interleukin‐6 and monocyte chemoattractant protein‐1 in chronic pancreatitis (2004) (15)
Release of leukotriene B4 and 5-hydroxyeicosatetraenoic acid during phagocytosis of artificial immune complexes by peripheral neutrophils in chronic inflammatory bowel disease. (1986) (15)
Effect of the leukotriene LTD4/LTE4 antagonist, SR 2640, in ulcerative colitis: an open clinical study. (1991) (15)
Telomere dysfunction instigates inflammation in inflammatory bowel disease (2021) (15)
[The influence of adhesion molecules in inflammatory bowel diseases]. (1997) (14)
Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn's disease. (2011) (14)
Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease (1991) (14)
Autoantibodies to Molecular Targets in Neutrophils in Patients with Ulcerative Colitis (1999) (14)
Comparison of an open and a closed tube system for collection of jejunal juice. (1983) (14)
Prognosis After First-Time Myocardial Infarction in Patients With Inflammatory Bowel Disease According to Disease Activity: Nationwide Cohort Study (2014) (14)
Neuroblastoma. Evaluation of 60 cases. (1981) (13)
Serum Concentration and Chemotactic Activity of E-selectin (CD62E) in Inflammatory Bowel Disease (1994) (13)
Soluble interleukin-2 receptors in ulcerative colitis (1993) (13)
Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine (2018) (13)
Impact of feedback and monitoring on colonoscopy withdrawal times and polyp detection rates (2017) (13)
Identification of TNF-α-Responsive Promoters and Enhancers in the Intestinal Epithelial Cell Model Caco-2 (2014) (13)
A comparison of the effect of timegadine, levamisole, and D-penicillamine on human neutrophil metabolism of endogenous arachidonic acid and chemotaxis. (1988) (12)
A fully defined 3D matrix for ex vivo expansion of human colonic organoids from biopsy tissue. (2020) (12)
Sulfasalazine and its anti-inflammatory metabolite, 5-aminosalicylic acid: effect on arachidonic acid metabolism in human neutrophils, and free radical scavenging. (1987) (12)
Iron replacement therapy: do we need new guidelines? (2016) (12)
Signs, symptoms, metastatic spread and metabolic behavior of neuroblastomas treated in Denmark during the period 1943-1980. (1987) (12)
Correlation between Circulating Soluble ICAM-1 and Prednisolone-induced Amelioration of Ulcerative Colitis (2003) (12)
Treatment response and colonic gene expression in patients with Crohn's disease (2007) (12)
Tuft Cells and Their Role in Intestinal Diseases (2022) (12)
Biological Treatment of Crohn’s Disease (2013) (11)
Impaired sensitivity to β2 integrin-blocking in ICAM-1-mediated neutrophil migration in ulcerative colitis (2001) (11)
Adhesion molecules in inflammatory and neoplastic intestinal diseases. (1995) (11)
Objective Quantification of Immune Cell Infiltrates and Epidermal Proliferation in Psoriatic Skin: A Comparison of Digital Image Analysis and Manual Counting (2016) (11)
Continuous interferon-γ or tumor necrosis factor-α exposure of enterocytes attenuates cell death responses (2004) (11)
Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel disease (2002) (10)
[Regulation of cytokine production in inflammatory bowel disease]. (2006) (10)
Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis. (2020) (10)
IBD: Can TNF inhibitors be administered during the third trimester? (2013) (10)
Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy (2019) (10)
Integrative transcriptomic and metabonomic molecular profiling of colonic mucosal biopsies indicates a unique molecular phenotype for ulcerative colitis. (2015) (10)
Arachidonic acid and calcium metabolism in rnelittin stimulated neutrophils (1992) (9)
Leukotriene B4 receptor levels and intracellular calcium signalling in polymorphonuclear leukocytes from patients with Crohn's disease. (1995) (9)
Quantification of specific E. coli in gut mucosa from Crohn's disease patients. (2011) (9)
[Development of colorectal cancer in ulcerative colitis]. (2010) (9)
Microarrays and Crohn's disease: Collecting reliable information (2005) (9)
Continuous interferon-gamma or tumor necrosis factor-alpha exposure of enterocytes attenuates cell death responses. (2004) (8)
Interleukin-2 receptor α and β chain expression by circulating αβ and γδ T cells in inflammatory bowel disease (1995) (8)
Impaired sensitivity to beta 2 integrin-blocking in ICAM-1-mediated neutrophil migration in ulcerative colitis. (2001) (8)
Source of endogenous arachidonate and 5-lipoxygenase products in human neutrophils stimulated by bradykinin and A23187. (1988) (8)
A simple filter-paper technique allows detection of mucosal cytokine levels in vivo in ulcerative colitis. Interleukin-1 and interleukin-1-receptor antagonist. (1996) (8)
CARD15 Status and Familial Predisposition for Crohn's Disease and Colonic Gene Expression (2007) (8)
[A reference program for children with urinary tract infection. A proposal for diagnosis and treatment of children with urinary tract infection]. (1999) (8)
Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha. (2006) (8)
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron‐containing medicines (2014) (8)
IBD metabonomics predicts phenotype, disease course, and treatment response (2021) (8)
Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease. (1998) (7)
Are NOD2 polymorphisms linked to a specific disease endophenotype of Crohn's disease? (2011) (7)
Tube for sampling of uncontaminated small-bowel juice. (1983) (7)
Spontaneous aggregation of leukocytes in active ulcerative colitis might be ICAM-1 dependent (2004) (7)
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis (2022) (7)
Inflammatory bowel disease: potential therapeutic strategies. (1997) (7)
[The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine]. (2009) (6)
[Inflammatory bowel disease--do microorganisms play a role?]. (2002) (6)
[Apoptosis in chronic inflammatory bowel disease. The importance for pathogenesis and treatment]. (2003) (6)
[Increased incidence of Crohn disease in the county of Copenhagen]. (1993) (6)
Regulation of Laminin γ2 Expression by CDX2 in Colonic Epithelial Cells Is Impaired During Active Inflammation (2017) (6)
Which Biological Agents Are Most Appropriate for Ulcerative Colitis? (2014) (6)
Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer (2022) (6)
Response to multimodal treatment in advanced neuroblastomas. Factors associated with complete remission induction, and factors associated with prolonged survival. (1989) (6)
Arachidonic acid metabolism in neutrophil granulocytes obtained from synovial fluid in rheumatoid arthritis. (1990) (5)
Relation between NOD2 genotype and changes in innate signaling in Crohn’s disease on mRNA and miRNA levels (2017) (5)
Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas. (1991) (5)
Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application. (2015) (5)
Concentrations of IgA, secretory IgA, IgM, secretory IgM, IgD, and IgG in the upper jejunum of children without gastrointestinal disorders. (1988) (5)
Ca2+ response in neutrophils after exposure to bacterial N-formyl-methionyl-leucyl-phenylalanine: delayed response in ulcerative colitis (2003) (5)
Apoptose ved kronisk inflammatorisk tarmsygdom. Betydning for patogenese og behandling (2003) (5)
Caspase 14 does not influence intestinal epithelial cell differentiation (2013) (4)
Insulin-like Growth Factor Binding Protein 3 in Inflammatory Bowel Disease (2005) (4)
Immune checkpoint Inhibitor-Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis. (2022) (4)
Gastric mucosal interleukin-8 and IL-8 antibody concentrations related to prevailing Helicobacter pylori infections. A Danish-Albanian study. (1999) (3)
Selective tyrosine kinase 2 inhibitors in inflammatory bowel disease. (2022) (3)
In vitro Superoxide Production by Peripheral Neutrophils from Patients with Inflammatory Bowel Disease (1994) (3)
[Extraintestinal manifestations in inflammatory bowel disease]. (2009) (3)
Immunohistochemistry in Tumor Diagnosis: External Quality Assessment of 13 Departments of Pathology in Western Denmark (1997) (3)
Methotrexate for inflammatory bowel disease: time for reconsideration (2019) (3)
Single-cell characterisation of mononuclear phagocytes in the human intestinal mucosa (2021) (3)
Safety and Efﬁcacy of Recombinant Human Interleukin 10 in Chronic Active Crohn’s Disease (2000) (3)
Comparative Studies of Superoxide Production by Microbial Wall Product-Primed Neutrophils in Ulcerative Colitis (2004) (3)
Serum interferon activity in inflammatory bowel disease (1988) (3)
[Increased risk of venous thromboembolism and arterial cardiovascular events in patients with inflammatory bowel disease]. (2012) (3)
Metabonomics in Gastroenterology and Hepatology (2019) (3)
Interleukin-2 receptor alpha and beta chain expression by circulating alpha beta and gamma delta T cells in inflammatory bowel disease. (1995) (3)
Biosimilars for Management of Crohn Disease (2018) (3)
Demonstration of circulating immune complexes by the indirect leucocyte phagocytosis test in chronic inflammatory bowel disease. Relation to results of a standard complement consumption assay. (2009) (3)
LFA-1 subunit expression in ulcerative colitis patients (1996) (2)
[Pharmacogenetics--new therapeutic possibilities]. (2005) (2)
[Transdermal nicotine treatment of ulcerative colitis: a survey of a Cochrane review]. (2006) (2)
ADRENOGENITAL SYNDROME AND CYSTIC FIBROSIS (1982) (2)
Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-Analysis. (2022) (2)
[Malignant solid tumors in children]. (1999) (2)
Reference values of sweat sodium obtained by pilocarpine iontophoresis (1987) (2)
Multiparametric and accurate functional analysis of genetic sequence variants using CRISPR-Select (2022) (2)
An open prospective study evaluating efficacy and safety of a new medical device for rectal application of activated carbon in the treatment of chronic, uncomplicated perianal fistulas (2016) (2)
The circulating common gamma chain in inflammatory bowel disease (1997) (2)
Effects of glucocorticoids on circulating concentrations of soluble intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis (2001) (2)
[5-amino-salicylic acid. A review of a new treatment of chronic inflammatory bowel disease]. (1985) (2)
Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease (2015) (1)
Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets (2022) (1)
[The Danish Committees on Scientific Dishonesty should be strengthened]. (2013) (1)
[Microscopic colitis--a missed diagnosis?--a secondary publication]. (2005) (1)
Transdermal nikotinbehandling af colitis ulcerosa: gennemgang af et Cochrane-reviewa survey of a Cochrane review (2006) (1)
Inflammatory bowel disease increases the risk of atrial fibrillation, particularly during active disease stages. a nationwide cohort study (2013) (1)
[Abdominal neuroblastoma. An analysis of 48 cases]. (1980) (1)
[Sweat electrolyte analysis by pilocarpine iontophoresis]. (1981) (1)
Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies (2018) (1)
Pediatric Tube System for Collection of Uncontaminated Jejunal Juice (1983) (1)
Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: The immunological network: Novel approaches to the treatment of Crohn's disease (1996) (1)
W1568 Inhibitor of Apoptosis Protein-2 (cIAP2) Is Important for Colonic Epithelial Wound Healing (2009) (1)
Tu1928 TNF-a-Induced Down-Regulation of CDx2 Suppresses Mep1a Expression in Colitis: A Potential Pathogenetic Key Factor in IBD (2012) (1)
Deucravacitinib (Sotyktu™) for plaque psoriasis. (2023) (1)
[Travel medicine--an important field in the globalization]. (2005) (1)
Microscopic colitis: Etiopathology, diagnosis, and rational management (2022) (1)
Induction of endogenous arachidonic acid metabolism in human neutrophils with snake venom phospholipase A2, immune complexes, and A23187. (1990) (1)
[Perioperative blood transfusion and colorectal cancer recurrence: a survey of a Cochrane review]. (2006) (1)
Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond (2012) (1)
[Blau syndrome in monozygotic twins]. (2006) (1)
Influence of helicobacter pylori on gastric interleukin-8 synthesis in a danish and an albanian patient population (1995) (1)
[Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn disease. A survey of a Cochrane review]. (2008) (1)
Octreotide does not improve response to corticosteroids in severe ulcerative colitis (1998) (1)
B2 integrins inhibit ICAM-1 induced neutrophil locomotion in ulcerative colitis (2000) (1)
Standard dosage schemes of omeprazole in the treatment of gastroesophageal reflux disease (GERD) - an objectional practice? (1995) (1)
Transgastric necrosectomy in severe acute (2005) (1)
Anti-TNF-α Therapy for Extraintestinal Manifestations of Inflammatory Bowel Disease (2015) (1)
[Chronic inflammatory intestinal disease and pregnancy]. (1984) (1)
[Antibiotic treatment of Clostridium difficile associated diarrhea in adults. A survey of a Cochrane review]. (2006) (1)
[Ulcerative colitis]. (2013) (1)
[Omphalopagus twins separated in the vagina during labor]. (1985) (1)
1031 Integration of Transcriptomics and Metabonomics: Improving Diagnostics and Phenotyping in Ulcerative Colitis (2013) (1)
NKG2D Expression and Function of T Cells Differs in Inflammatory Bowel Disease: 1629 (2012) (0)
[The search for yet unrecognized infectious pathogens]. (2002) (0)
Abnormal metabolism ofarachidonic acid inchronic inflammatory boweldisease: enhanced release of leucotriene B4 fromactivated neutrophils (1987) (0)
[Inflammation and free oxygen radicals]. (1989) (0)
Mo1853 - Characterization of Inflammatory Phenotypes in Plasma from Anti-TNF Anti-Integrin Refractory IBD Patients (2018) (0)
[Biological drugs in the treatment of immunoinflammatory diseases]. (2008) (0)
[Mesalamine in the treatment of Crohn disease?]. (2005) (0)
Su1756 Overexpression of Mknk2 and Thr-α in Dysplastic Inflamed Colonic Mucosa Correlates to the Risk of Colorectal Cancer in Pancolitis (2013) (0)
Expression of Common Gamma Chain on Peripheral Blood Mononuclear Cells in Crohn's Disease (1997) (0)
P039 Tracking intestinal epithelial cells with fluorescent dyes (2019) (0)
A simple filter-paper technique allows detection of mucosal cytokine levelsin vivo in ulcerative colitis (1996) (0)
[Association between Helicobacter pylori infection and ventricular cancer--more than a suspicion. The Danish Society of Gastroenterology]. (2002) (0)
[5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review]. (2011) (0)
Sa1682 TNF-α-Mediated Down-Regulation of CDx2 Decreases the Expression of β-Catenin Degradation Complex Genes in Colorectal Cancer (2013) (0)
ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis (2013) (0)
Su1294 Clinical Features and Prognosis of Coexisting Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Population-Based Cohort Study 1977-2011 (2015) (0)
Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy (2019) (0)
Soluble L-selectin levels and colonic CD34 expression in inflammatory bowel disease (1998) (0)
Tu1266 IMPAIRED VITAMIN D RECEPTOR EXPRESSION AND SIGNALING IN ULCERATIVE COLITIS INTESTINAL EPITHELIAL CELLS (2020) (0)
[Mesalazine for maintenance of medically-induced remission in Crohn disease: a survey of a Cochrane review]. (2005) (0)
S765 Paternal Biologic and Thiopurine Exposure in Inflammatory Bowel Disease and Association With Adverse Pregnancy Outcomes and Semen Parameters: A Systematic Review and Meta-Analysis (2021) (0)
[Inflammation and free oxygen radicals]. (1989) (0)
Sa1173 The T300A Variant of ATG16L1 Affects Clinical Course and Risk of Surgery in Crohn's Disease (2015) (0)
Interleukin-17 mRNA in active inflammatory bowel disease (1998) (0)
Micturition-cysto-urethrography in infancy and childhood. (1967) (0)
Recent therapeutic advances in inflammatory bowel disease. (2002) (0)
Tu1879 Cellular Flice Inhibitory Protein (C-FLIP) Regulates of Epithelial Cell Apoptosis in Ulcerative Colitis in an ERK Dependent Manner (2012) (0)
P663 The effect of vitamin D deficiency, and its correction, on healthcare utilisation among patients with inflammatory bowel disease (IBD) (2019) (0)
P651 Association between Crohn's disease and small bowel cancers: a Danish nationwide population based study (2013) (0)
[Letter: Treatment of congenital pyloric stenosis]. (1975) (0)
Effects of antirheumatic drugs on endogenous arachidonate metabolism and chemotaxis in human neutrophil granulocytes (2005) (0)
Tu1832 Homeostatic Regulation of Laminin γ2 Expression by CDx2 in Colonic Epithelial Cells Is Impaired During Active Inflammation (2015) (0)
[Dagens Medicin: disastrous waste of research resources]. (2005) (0)
P787 Vitamin D status and clinical outcomes in inflammatory bowel disease patients: a systematic review and meta-analysis (2019) (0)
[Where are we going?]. (2004) (0)
Subject Index Vol. 30, Suppl. 3, 2012 (2013) (0)
[Magnetic resonance colonography: a new diagnostic tool]. (2005) (0)
P072 Ezrin, LAMC2 and ITG α 6 as possible biomarkers of ulcerative colitis-associated colonic dysplasia (2013) (0)
P059 Importance of NOD2 on mRNA and miRNA signatures in monocytes from Crohn's disease (2014) (0)
Su1198 Metabonomics of Human Fecal Extracts - Gut Microbiota Characteristics and a Diagnostic Tool in Inflammatory Bowel Disease (2013) (0)
[Copy is fraudulent--but what is the consequence?]. (2006) (0)
Low ileal IL-10 mRNA levels predict endoscopic recurrence in patients operated on for Crohn's disease (CD) (2000) (0)
[How far are we from the clinical use of array technology?]. (2005) (0)
Deucravacitinib (Sotyktu) for plaque psoriasis. (2023) (0)
How should we use azathioprine and 6-mercaptopurine in inflammatory bowel disease? (2006) (0)
Long-TermGynecological Outcomes inWomen with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (2010) (0)
Abdominal pain caused by enterobius vermicularis: a case report (1985) (0)
P435 Management of iron deficiency in inflammatory bowel disease: results from a RAND/UCLA appropriateness study (2013) (0)
[New guidelines on good scientific practice]. (2009) (0)
Su1170 New Evidence Indicates Mir-20b, Mir-98, Mir-125b-1*, and Let-7e* to Be Involved in the Pathogenesis of Ulcerative Colitis (2013) (0)
Su1113 ESTABLISHING HUMAN COLONIC ORGANOIDS FROM TISSUE BIOPSIES IN A FULLY-DEFINED HYDROGEL (2020) (0)
University of Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals (2015) (0)
Overexpression of Receptors for Insulin and Epidermal Growth Factor in Dysplastic Inflamed Colonic Mucosa Correlates With Increased Cancer Risk in Patients With Ulcerative Colitis (2011) (0)
M1824 Inhibitor of Apoptosis Protein 2 (cIAP2) Overexpression in Cytokine Stimulated Colonocytes Modifies Inflammation Driven Propagation of DNA-Damaged Cells (2010) (0)
Su1912 Discrimination Between IBD and Controls Using Multigene Analysis of Seven Specific Genes (2012) (0)
Su1117 HUMAN COLONIC ORGANOIDS EXPRESS A SUBSET OF EICOSANOID RECEPTORS CONTROLLING CELL DIFFERENTIATION AND INFLAMMATORY RESPONSES (2020) (0)
Pitfalls of anticytokine autoantibody ELISA: false-positive results in Crohn's disease with hyperimmunoglobulinemia. (1996) (0)
[The role of micro-ribonucleic acid in disease development]. (2009) (0)
Tu1239 CIAP INHIBITION WITH SMAC MIMETICS IN MONOCYTES OF CROHN'S DISEASE DECREASE TLR4 MEDIATED CYTOKINE PRODUCTION VIA NON-NECROPTOTIC RIPK1 INHIBITION (2020) (0)
Sa1786 - Plasma Cytokine Profiles in IBD Primary Non-Responders Versus Responders to Infliximab (2018) (0)
[Transplantation: ethics and stem cells]. (2003) (0)
Tu1663 No Increased Potency of Mycobacteria Derived N-Glycolyl Muramyl Dipeptide on NOD2 and ATG16L1-Mediated Human Immune Response (2013) (0)
[Paracetamol increases the risk of upper gastrointestinal hemorrhage and perforation]. (2001) (0)
Characterization of leukocytes in distinct human intestinal compartments (2017) (0)
[Significance of free oxygen radicals for pathogenesis of chronic inflammatory disease]. (1992) (0)
This is a reply of a "Letter to the Editor" by Volger S and Scherl E (Reference 1) dealing with our article. (2021) (0)
Relation between NOD2 genotype and changes in innate signaling in Crohn’s disease on mRNA and miRNA levels (2017) (0)
[Microarray data analysis]. (2006) (0)
[Primary human intestinal epithelial cells as a tool to clarify disease mechanisms]. (2013) (0)
S1197 Metabonomics As a Diagnostic Tool of Ulcerative Colitis (2008) (0)
[Induction of remission with TNF-alpha inhibitor in Crohn disease. An analysis of a systematic Cochrane review]. (2004) (0)
Molecular Manipulations and Intestinal Stem Cell-Derived Organoids in Inflammatory Bowel Disease. (2022) (0)
Entero-urinary fistulas in Crohn ’ s disease : prevalence and clinical manifestations (2013) (0)
[Publication ethics, national and international regulations]. (2003) (0)
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals (2014) (0)
Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis (2013) (0)
[Azathioprine and 6-mercaptopurine for maintenance treatment in ulcerative colitis. A survey of a Cochrane review]. (2007) (0)
Mo1114: IMMUNE CHECKPOINT INHIBITOR-INDUCED DIARRHEA AND COLITIS: INCIDENCE AND MANAGEMENT. A SYSTEMATIC REVIEW AND METAANALYSIS (2022) (0)
[Treatment of collagenous colitis. An analysis of a systematic Cochrane review]. (2003) (0)
[Physicians' participation in clinical drug trials]. (2003) (0)
S1187 Colonic Pre-Inflammation in Quiescent Ulcerative Colitis Is Due to the Presence of Lamina Propria Residing Cells (2008) (0)
[TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review]. (2007) (0)
[Familial polycystic syndrome. An unexpected finding at operation]. (1980) (0)
W1626 A NOD2-Mutant-Like Phenotype in Wild Type NOD2 Monocytes from Crohn's Disease Patients (2009) (0)
Expression of the stem cell markers HOF and nestin in glioblastoma. (2006) (0)
[Congenital duodenal obstruction caused by an abnormal superior mesenteric vein]. (1990) (0)
Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis (2023) (0)
Enhanced capacity forrelease ofleucotriene B4by neutrophils inrheumatoid arthritis (2011) (0)
Su1189 Genome-Wide Discovery of Inflammatory Bowel Disease-Specific Transcriptional Enhancers and Promoters Identifies Powerful Diagnostic Biomarkers (2015) (0)
Lack of Effect of Cyclosporine a on Endogenous Arachidonic Acid Metabolism in Human Neutrophils (1987) (0)
Serum from NSAID-treated patients attenuates the capacity of rat leukocytes to synthesize leukotriene B4 (2005) (0)
Syddansk Universitet A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases (2017) (0)
Altered colonic synthesis of interleukin-13 and -15 in ulcerative colitis and Crohn's disease (1998) (0)
Noninfectious & noninflammatory bowel disease colitis (2013) (0)
[Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites]. (2005) (0)
[Biliary atresia and neonatal hepatitis. Differential diagnosis and therapeutic possibilities in neonatal cholestatic hepatitis]. (1982) (0)
Receptors In vitro superoxide production by peripheral neutrophils from patients with inflammatory bowel disease (0)
Su1996 - Loading and Tracking Intestinal Organoids with Fluorescent Plga Nanoparticles (2018) (0)
Cardiac tamponade as the first manifestation of pulmonary malignancy, two case reports (1991) (0)
Chemotactic properties of ICAM-1 and PECAM-1 on neutrophils in ulcerative colitis: Influence of prednisolone (2000) (0)
[The multicystic kidney. 3 bilateral and 17 unilateral cases]. (1986) (0)
Selective JAK1 inhibitors for the treatment of inflammatory bowel disease. (2023) (0)
[Intermittent hydronephrosis and a ureteral polyp in an 8-year-old boy]. (1985) (0)
10: REDUCED COLONIC VITAMIN D RECEPTOR SIGNALING IN FLARING ULCERATIVE COLITIS DUE TO A SPECIFIC LOSS OF CRYPT TOP EPITHELIAL CELLS (2022) (0)
Su1241 Circulating Alpha-1 Antitrypsin (AAT) and Granulocyte Colony-Stimulating Factor (G-CSF) Grade Disease Severity in Ulcerative Colitis (2015) (0)
[Alternatives to splenectomy]. (1982) (0)
Increased numbers of interleukin-15 expressing peripheral blood cells in active ulcerative colitis (1996) (0)
Increased risk of major adverse cardiovascular events during flares after first-time myocardial infarction in inflammatory bowel disease: a nationwide cohort study (2014) (0)
Anti-Inflammatory Effects of Smac-Mimetic BV6 on Immune Cells in Crohn's Disease (2017) (0)
Inflammatory Bowel Disease Is Associated With an Increased Risk of Hospitalization for Heart Failure (2014) (0)
Interleukin-2 Receptor oL and 13 Chain Expression by Circulating oLI3 and T Cells in Inflammatory Bowel Disease (1995) (0)
NEUROBLASTOMA (1981) (0)
Expression of tumor stem cell markers in glioblastoma multiforme (2006) (0)
Jul 15, 2021 Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming (2020) (0)
Tu1860 Inverse Expression of IL-33 in TH1 Versus TH2 Mediated Experimental Colitis (2012) (0)
Digestive Disease Week 2001. Novel therapeutic principles in inflammatory bowel disease. 20-23 May 2001, Atlanta, GA, USA. (2001) (0)
[Ulcerative colitis]. (2014) (0)

This paper list is powered by the following services:

Other Resources About Ole Haagen Nielsen

curis.ku.dk

What Schools Are Affiliated With Ole Haagen Nielsen?

Ole Haagen Nielsen is affiliated with the following schools:

Ole Haagen Nielsen's Academic­Influence.com Rankings

Ole Haagen Nielsen's Degrees

Similar Degrees You Can Earn

Why Is Ole Haagen Nielsen Influential?

Ole Haagen Nielsen's Published Works

Published Works

Other Resources About Ole Haagen Nielsen

What Schools Are Affiliated With Ole Haagen Nielsen?

Ole Haagen Nielsen's AcademicInfluence.com Rankings